Advanced Biomed Inc. (ADVB)
ADVB trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$5.16
-2.18% on the day
Market cap
$8.5M
Nano cap
Revenue · 2026
$128K
No prior year to compare
Net income · 2026
$6.7M
5231.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:Revenues), period ending 2026-06-30, https://www.sec.gov/Archives/edgar/data/1941029/000121390026109029/0001213900-26-109029-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2026-06-30.
Profile
| Field | Value |
|---|---|
| Ticker | ADVB on Nasdaq |
| Sector | Health Care |
| Industry | Medical Specialities |
| Country | Taiwan |
| IPO year | 2025 |
| SEC CIK | 0001941029 |
| SEC industry code | Services-Medical Laboratories |
| Incorporated in | NV |
Financials · 2026
| Line | Value |
|---|---|
| Revenue | $128K |
| Net income | $6.7M |
| Operating income | Not in SEC XBRL data |
| Net margin | 5231.3% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | 1.3× |
| P/S (computed) | 66.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document REGISTRATION STATEMENT | S-1 | 2025-07-23 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-10-13 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-05-15 |
| Latest current report CURRENT REPORT | 8-K | 2026-07-17 |
| Latest proxy DEFINITIVE PROXY STATEMENT | DEF 14A | 2026-06-04 |
Source: SEC EDGAR submissions feed, 98 recent filings. All filings on EDGAR.
Peers in Medical Specialities
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| AMS | American Shared Hospital Services | $1.27 | 0.00% | $8.4M |
| ACON | Aclarion Inc. | $2.14 | -4.68% | $6.2M |
| BGLC | BioNexus Gene Lab Corp | $1.32 | -5.01% | $3.9M |
| ACH | Accendra Health Inc. | $0.3151 | -19.31% | $24.2M |
| MDXH | MDxHealth SA | $0.6600 | +9.29% | $63.0M |
| SERA | Sera Prognostics Inc. | $2.04 | -1.45% | $80.5M |
| KEQU | Kewaunee Scientific Corporation | $32.20 | -0.62% | $93.2M |
| BNR | Burning Rock Biotech Limited | $15.00 | 0.00% | $158.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier